Director Booth Bruce exercised 11,741 shares at a strike of $20.00 and sold $45,293,294 worth of shares (478,198 units at $94.72) as part of a pre-agreed trading plan (SEC Form 4)
4 - Kymera Therapeutics, Inc. (0001815442) (Issuer)
Live Feed
Delayed 3mPress · Analyst · Insider · SEC · FDA · Financials
Signed out · 3-min delay · Sign up for real-time
- SEC Form 3 filed by new insider Law Adam R.
3 - Nine Energy Service, Inc. (0001532286) (Issuer)
- CEO and Executive Chairman Farkas Michael D gifted 1,000,000 shares, decreasing direct ownership by 2% to 62,497,924 units (SEC Form 4)
4 - NEXTNRG, INC. (0001817004) (Issuer)
- EVP & Chief Dev. Officer Lynds Gregory S exercised 6,201 shares at a strike of $37.70 and sold $346,388 worth of shares (6,201 units at $55.86) (SEC Form 4)
4 - BJs RESTAURANTS INC (0001013488) (Issuer)
- Director Chaurasia Bina was granted 2,955 shares, increasing direct ownership by 16% to 20,999 units (SEC Form 4)
4 - BJs RESTAURANTS INC (0001013488) (Issuer)
- Director Richmond C Bradford was granted 2,955 shares, increasing direct ownership by 9% to 37,702 units (SEC Form 4)
4 - BJs RESTAURANTS INC (0001013488) (Issuer)
- Director Dal Pozzo James was granted 2,955 shares, increasing direct ownership by 11% to 30,092 units (SEC Form 4)
4 - BJs RESTAURANTS INC (0001013488) (Issuer)
- Director Robinson Julius was granted 2,955 shares, increasing direct ownership by 20% to 17,838 units (SEC Form 4)
4 - BJs RESTAURANTS INC (0001013488) (Issuer)
- Director Sherlock Janet was granted 2,955 shares, increasing direct ownership by 13% to 26,199 units (SEC Form 4)
4 - BJs RESTAURANTS INC (0001013488) (Issuer)
- Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN MATEO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in 1x1 investor meetings at the Leerink Partners Therapeutics Forum in Boston, MA on July 15, 2026. Inducement Grant In connection with the hiring of two employees, the Compensation Committee of Sagimet’s Board of Directors approved that an inducement grant of 34,300 stock options, in aggregate to purchase shares of the Company’s Series A common stock, be granted on June 22, 2026 to the newly hired employees. The option
- SEC Form 4 filed by President and CEO Vexler Amir Vadim
4 - CENTRUS ENERGY CORP (0001065059) (Issuer)
- SEC Form 4 filed by SVP, CFO & Treasurer Tinelli Todd M
4 - CENTRUS ENERGY CORP (0001065059) (Issuer)
- SEC Form 4 filed by SVP, GC, CCO & Corp Sec Emery Richard Dingley Iii
4 - CENTRUS ENERGY CORP (0001065059) (Issuer)